Nab-paclitaxel trials for Pancreatic Ductal Adenocarcinoma

All Nab-paclitaxel trials · All Pancreatic Ductal Adenocarcinoma trials

Phase breakdown

Recruiting trials studying Nab-paclitaxel for Pancreatic Ductal Adenocarcinoma

• A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
  NCT07024615 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• AB122 Platform Study
  NCT04999761 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
  NCT06586515 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 104 locations
• Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
  NCT05254171 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 93 locations
• Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
  NCT06445062 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 64 locations

Common questions

How many trials study Nab-paclitaxel for Pancreatic Ductal Adenocarcinoma?

5 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.